UBS Maintains Buy on Ascendis (ASND), Sees Upside from Yorvipath Data
Ascendis Pharma A/S (NASDAQ:ASND) ranks among the best biotech stocks to buy.
Ascendis Pharma A/S (ASND)
This company is not actively trading or the ticker does belong to another company in our database now.
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 1,481,000 | $2,024,186 | -2% | 0.1% | |
| 2. | Bayforest Capital Theodoros Tsagaris | 0 | $0 | 0% |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,882,781 | $374,315,689 | 0.12% | |
| 2. | 793,677 | $157,790,924 | 0.08% | |
| 3. | 93,235,000 | $127,161,015 | 0.94% | |
| 4. | 209,298 | $41,610,503 | 0.01% | |
| 5. | 191,672 | $39,122,172 | 0.06% |
News See All
14 Best Biotech Stocks to Buy Right Now
The biotech industry is almost always buzzing. However, there has been some unanticipated activity in this sector of late.
11 Best Performing Long Term Stocks According to Analysts
Alli McCartney of UBS noted that the market’s behavior after the recent Fed rate cut was unusual. On the day of the cut, major indices closed lower except for the Russell 2000.
Morgan Stanley Remains Bullish on Ascendis Pharma (ASND)
Ascendis Pharma A/S (NASDAQ:ASND) is one of the top high growth international stocks to buy right now.
13 High Growth International Stocks to Buy Right Now
On September 12, CNBC reported that according to data released the same day, the UK economy recorded zero growth in July after expanding by 0.4% in June.
Ascendis Pharma A/S (NASDAQ:ASND) Q2 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Q2 2025 Ascendis Pharma Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.
Ascendis Pharma A/S (ASND) Delivers Positive Trial Results for Hypoparathyroidism Treatment
Ascendis Pharma A/S (NASDAQ:ASND) is one of the best biotech stocks to buy according to billionaire Steve Cohen.
10 Best Biotech Stocks to Buy According to Billionaire Steve Cohen
Steve Cohen, whose success at SAC Capital made him one of the most successful hedge fund managers on Wall Street, is a worried man.
Oppenheimer Hikes Ascendis Pharma Price Target on Strong Yorvipath Demand Outlook
Ascendis Pharma A/S (NASDAQ:ASND) is one of billionaire Stan Druckenmiller’s top stock picks with huge upside potential.
Billionaire Stan Druckenmiller's 10 Stock Picks with Huge Upside Potential
Stanley Druckenmiller, an American billionaire investor, is the founder of Duquesne Capital.
Hedge Fund Resource Center Billionaire Hedge Funds
